{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:36:47Z","timestamp":1789753007779,"version":"4.0.1"},"reference-count":33,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,12,29]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.2967\/jnumed.125.271273","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T15:45:14Z","timestamp":1768578314000},"page":"501-505","source":"Crossref","is-referenced-by-count":1,"title":["LASER: A Phase 2 Trial of\n                    <sup>177<\/sup>\n                    Lu-PSMA-617 as Systemic Therapy for RCC"],"prefix":"10.2967","volume":"67","author":[{"given":"Shir","family":"Hazut Krauthammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"LaBrecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliane","family":"Kabarame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Serzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas R.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao X.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni K.","family":"Choueiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Jacene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praful","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026040105551068000_67.4.501.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"2026040105551068000_67.4.501.2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur Urol."},{"key":"2026040105551068000_67.4.501.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0211-5"},{"key":"2026040105551068000_67.4.501.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"2026040105551068000_67.4.501.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714"},{"key":"2026040105551068000_67.4.501.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035716"},{"key":"2026040105551068000_67.4.501.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026982"},{"key":"2026040105551068000_67.4.501.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510016"},{"key":"2026040105551068000_67.4.501.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70093-7"},{"key":"2026040105551068000_67.4.501.10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(19)30735-1","article-title":"Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study","volume":"21","author":"Rini","year":"2020","journal-title":"Lancet Oncol."},{"key":"2026040105551068000_67.4.501.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00290-9"},{"key":"2026040105551068000_67.4.501.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313906"},{"key":"2026040105551068000_67.4.501.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00922-4"},{"key":"2026040105551068000_67.4.501.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01758-6"},{"key":"2026040105551068000_67.4.501.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(98)00278-7"},{"key":"2026040105551068000_67.4.501.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30314-7"},{"key":"2026040105551068000_67.4.501.17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/jamaoncol.2021.3771","article-title":"Diagnostic accuracy of 68Ga-PSMA-11 PET for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection: a multicenter prospective phase 3 imaging trial","volume":"7","author":"Hope","year":"2021","journal-title":"JAMA. Oncol."},{"key":"2026040105551068000_67.4.501.18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA. Oncol."},{"key":"2026040105551068000_67.4.501.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30198-0"},{"key":"2026040105551068000_67.4.501.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026040105551068000_67.4.501.21","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0140-6736(24)01653-2","article-title":"177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial","volume":"404","author":"Morris","year":"2024","journal-title":"Lancet."},{"key":"2026040105551068000_67.4.501.22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.urology.2007.03.025","article-title":"Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms","volume":"70","author":"Baccala","year":"2007","journal-title":"Urology."},{"key":"2026040105551068000_67.4.501.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267417"},{"key":"2026040105551068000_67.4.501.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"2026040105551068000_67.4.501.25","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551068000_67.4.501.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(00)01094-3"},{"key":"2026040105551068000_67.4.501.27","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/oncolo\/oyae181.054","article-title":"Preclinical evaluation of PSMA-based68Ga-\/225Ac-labeled radiotheranostic pair in a syngeneic mouse model of renal cell carcinoma [abstract]","volume":"29","author":"Thotakura","year":"2024","journal-title":"Oncologist."},{"key":"2026040105551068000_67.4.501.28","doi-asserted-by":"crossref","first-page":"192.e21","DOI":"10.1016\/j.urolonc.2024.10.013","article-title":"Gene expression of prostate-specific membrane antigen (FOLH1) in clear cell renal cell carcinoma predicts angiogenesis and response to tyrosine kinase inhibitors","volume":"43","author":"Khaleel","year":"2025","journal-title":"Urol Oncol."},{"key":"2026040105551068000_67.4.501.29","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.17037"},{"key":"2026040105551068000_67.4.501.30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13550-025-01232-8","article-title":"Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)","volume":"15","author":"Binzaqr","year":"2025","journal-title":"EJNMMI Res."},{"key":"2026040105551068000_67.4.501.31","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004725"},{"key":"2026040105551068000_67.4.501.32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12885-023-11702-8","article-title":"A multicentric, single arm, open-label, phase I\/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR)","volume":"24","author":"Kryza","year":"2024","journal-title":"BMC Cancer."},{"key":"2026040105551068000_67.4.501.33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13550-024-01156-9","article-title":"All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful","volume":"14","author":"Bogsrud","year":"2024","journal-title":"EJNMMI Res."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:18Z","timestamp":1785269898000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.2967\/jnumed.125.271273"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271273","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}